--South Africa's Competition Commission gave conditional approval to a proposed joint venture between pharmaceutical companies GlaxoSmithKline PLC (GSK) and Pfizer Inc. (PFE), Reuters reported Tuesday.

--The Commission suggested the JV continue to use South African manufacturer and packager Spechparm Holdings for three years, in an effort to alleviate the impact of the deal on local companies working for Pfizer, the report said.

 

Full story: https://www.reuters.com/article/us-pfizer-gsk-jointventure/gsk-pfizer-joint-venture-gets-conditional-approval-from-south-africas-competition-regulator-idUSKCN1TX1MR

 

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

July 02, 2019 13:55 ET (17:55 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more GSK Charts.